NAPROXEN
- Product NDC
- 52605-139
- 11-digit product format
- 526050139
- Labeler code
- 52605
- Product ID
- 52605-139_d349356e-61d3-4728-8425-1a4d513605d9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NAPROXEN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Polygen Pharmaceuticals LLC
- Application
- ANDA091416
- Marketing category
- ANDA
- Marketing start
- 2012-02-01
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 375 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 52605-139-01 | NAPROXEN | 100 in 1 BOTTLE | TABLET | 100 | | 6 |
| 52605-139-05 | NAPROXEN | 500 in 1 BOTTLE | TABLET | 500 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 52605-139 | NAPROXEN TABLET [POLYGEN PHARMACEUTICALS LLC] | 6 | Legacy NDC, 2 package rows | 20130628_2e84d479-5536-471f-93ef-34c353aff071.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 52605-139-01 | 52605013901 | 100 in 1 BOTTLE | Historical |
| 52605-139-05 | 52605013905 | 500 in 1 BOTTLE | Historical |